Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7304 p755
19 June 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Privy Council nominee agrees to return to Society's Council

Michael Schofield: concerns remain

Michael Schofield has agreed to return to the Royal Pharmaceutical Society's Council following his resignation at the June meeting.

Professor Schofield, one of three members appointed by the Privy Council, resigned because he was concerned about the Society’s future direction following the change of President (PJ, 12 June, p749). The other two Privy Council nominees put the Council “on notice” until August.

The new President, Nicholas Wood, wrote to Professor Schofield to ask him to reconsider.

“Council has asked that I write to you with the request that you reconsider your decision to resign and that you remain, with the other two Privy Council Council members, on the Council up to the August Council meeting on the conditional basis that significant and satisfactory progress to resolve our difficulties is made by that time,” wrote Mr Wood. In his reply, Professor Schofield said: “Although I do have serious concerns, about which I will write to you privately, it would be discourteous not to accede to your request and I am happy to do this.”

Professor Schofield told The Journal: “I resigned because I was concerned about proper governance of the Council and about its direction of travel.”

At the time of his resignation, Professor Schofield said that he would write to the Privy Council, Department of Health and Council for the Regulation of Healthcare Professionals to report his concerns about the Council. He was about to so when he received the President’s letter. Although he has not written to the organisations, he points out that his concerns remain.

Over the next few months, Professor Schofield said that he would like to see “a recognition of the needs of governance and the development of a more collective spirit”.

Back to Top


©The Pharmaceutical Journal